Innovation
25 patent families (4 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 401 times.
| Year | Filings |
|---|---|
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 9 |
| 2024 | 7 |
| 2025 | 15 |
| 2026 | 5 |
Social engagement
Social engagement: 6.4K social following, 9 posts in the last 12 months — above the industry median.
Investor mix
5 investors on record; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Private equity | 2 | 40% |
| Other / undisclosed | 2 | 40% |
Recent activity
4 Jun 2026
Event
Jefferies Global Healthcare Conference
3 Jun 2026
Event
investor webcast on onvansertib in combination with standard-of-care regimens in first-line RAS-mutated metastatic colorectal cancer (mCRC)
2 Jun 2026
Event
ASCO 2026 Annual Meeting